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Background: The spore-bearing alkaliphilic Bacillus species constitute a large, heterogeneous group of
microorganisms, important for their ability to produce enzymes, antibodies and metabolites of potential medical
use. Some Bacillus species are currently being used for manufacturing probiotic products consisting of bacterial
spores, exhibiting specific features (colonization, immune-stimulation and antimicrobial activity) that can account for
their claimed probiotic properties. In the present work a comparative proteomic study was performed aimed at
characterizing the secretome of four closely related isogenic O/C, SIN, N/R and T B. clausii strains, already marketed
in a pharmaceutical mixture as probiotics.
Results: Proteomic analyses revealed a high degree of concordance among the four secretomes, although some
proteins exhibited considerable variations in their expression level in the four strains. Among these, some proteins
with documented activity in the interaction with host cells were identified, such as the glycolytic enzyme enolase,
with a putative plasminogen-binding activity, GroEL, a molecular chaperone shown to be able to bind to mucin,
and flagellin protein, a structural flagella protein and a putative immunomodulation agent.
Conclusion: This study shows, for the first time, differences in the secretome of the OC, SIN, NR and T B. clausii
strains. These differences indicate that specific secretome features characterize each of the four strains despite their
genotypic similarity. This could confer to the B. clausii strains specific probiotic functions associated with the
differentially expressed proteins and indicate that they can cooperate as probiotics as the secretome components
of each strain could contribute to the overall activity of a mixed probiotic preparation.
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Bacillus species (B. cereus, B. clausii, B. pumilus) are a
large, heterogeneous group of Gram-positive, nonpatho-
genic, spore-forming microorganisms, used in many
chemical, medical, and industrial processes taking advan-
tage of their wide range of physiological characteristics
and ability to secrete large amounts of extracellular
proteins as well as biochemicals, antibiotics and other
metabolites.
Mixtures of viable Bacillus spores have been marketed
as probiotic preparations [1]. Probiotics are defined as
microbial cell preparations or components of microbial* Correspondence: r.lippolis@ibbe.cnr.it
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reproduction in any medium, provided the orcells that can beneficially impact human health.
Probiotics have been shown to be useful in oral
bacteriotherapy and bacterioprophylaxis of gastrointes-
tinal disorders [2]. The positive effects of probiotics in
human diseases can be associated with synthesis of anti-
microbial substances, competition with pathogenic mi-
croorganisms, modification of toxins or toxin receptors,
and immune system modulation [3].
The present proteomic study was performed on four
O/C, SIN, NR and T Bacillus strains currently used as
probiotics, which proved to be useful in treating various
gastrointestinal disorders by improving the host intes-
tinal microbial balance [4], and in preventing side effects
in antibiotic therapy [5].
The use of the four Bacillus strains as probiotic species
is supported by more than 40 years of clinical observationsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Moreover, Bacillus strains exhibit unique properties such
as resistance to commonly used antibiotics [1], absence in
normal resident intestinal flora and sporogenic activity
[6,7]. Bacillus spores can survive in the acid gastric envir-
onment, and reach the intestinal tract where they germin-
ate to vegetative forms [8,9]. Little is known on how these
bacteria exert their therapeutic effects.
Recently, the four Bacillus strains have been character-
ized and catalogued as belonging to a unique genospecies
identified as the alkali-tolerant species and aligned with
members of Bacillus clausii subgroup, rather than with
Bacillus subtilis, as previously reported. The four B. clausii
strains display a low level of intra-species diversity and ex-
hibit a high degree of genomic conservation [4], with in-
herent intrinsic difficulty in identifying the role of each
strain in the probiotic function.
Our previous study described the proteomic profile of
the four O/C, SIN, N/R, and T, B clausii strains and led
to the recognition that the four strains, having the same
genotypic traits, exhibited, surprisingly, variations in the
expression level of several proteins [10]. This made pos-
sible to distinguish each of the four B. clausii strains
based on their 2-DE protein signature.
In the present study, proteomics was applied to obtain
a description of the extracellular proteome components
(secretome) of the four probiotic O/C, SIN, N/R, and T
B. clausii strains. Secreted proteins are involved in the
hydrolysis of natural polymers [11,12], in processes like
cell wall turnover, substrate binding or protein secretion
[13,14] as well as in regulating the onset of post-
exponential phase processes (competence, development
and sporulation) [15,16]. As secreted proteins come into
direct contact with host compartments, they can medi-
ate host-bacteria interactions. Despite the potential im-
portance of proteins secreted by probiotic strains, data
on their identity are very limited.
Proteomic analysis and identification of secreted pro-
teins differentially expressed in the four B. clausii strains
could provide definite information on their functional
features. The present study resulted in: i) detection and
identification of differentially expressed secreted pro-
teins, ii) identification of proteins related to specific pro-
biotic functions associated with each strain, iii) a better
understanding of how these microorganisms, character-
ized by a notable low level of intraspecies genome diver-




The four O/C, SIN, N/R and T B. clausii strains, now
propagated for production of commercial probiotic prepar-
ation, were obtained from Sanofi Winthrop, (Milan, Italy)as separate spore suspensions. The designation of these
strains was derived from their resistance to different anti-
biotic resistance markers: O/C was resistant to chloram-
phenicol, SIN was resistant to neomycin and streptomycin,
N/R was resistant to novobiocin and rifampicin and T was
resistant to tetracycline [1,17]. All strains were stored in a
glycerol stock solution at −80°C.
Strains and culture condition
Bacteria cells were plated directly from a glycerol stock so-
lution onto the LB medium agar plate. (Tryptone 10.0g,
Yeast extract 5.0 g, NaCl 5.0 g, H2Oad 1.0L) (Fluka, Buchs,
Switzerland).
O/C, N/R, SIN and T B. clausii strains were maintained
on LB-agar plates. The four strains were inoculated in LB
medium supplemented with 100 mM tricine pH 8.0, from
a stationary pre-culture. Growth was performed in 250 ml
flasks containing 50 ml of broth at 37°C in an orbital
shaker with radius of 5 cm at 150 rpm.
Bacteria growth was monitored by measuring the optical
density at 595 nm. Cultivation was started with an initial
optical density of about 0.04 at 37°C. Cells and culture
medium (CM) were collected at early exponential growth
phase (8 h), late exponential growth phase (16 h) and sta-
tionary growth phase (24 h) (Additional file 1: Figure S1).
The cultivation was performed in triplicate for each B.
clausii strain. Cells from each independent triplicate were
collected and proteins were extracted as described below.
Validation procedures
Before proceeding with the proteomic analysis of secreted
proteins, we verified that proteins detected in CM were
not artifacts due to the presence of degradation products
for spontaneous or inadvertent bacteria cell lysis or extra-
cellular proteases degradation. To minimize degradation
of secreted proteins by proteases, during CM collection
and protein preparation, a protease inhibitor (1 mM
phenylmethylsulfonyl fluoride (PMSF)), (Sigma-Aldrich,
St. Louis, MO, USA) was included in CM.
To eliminate bacterial cells from CM, the supernatant
was filtered through a 0.2mm low protein-binding miller
filter (Millipore) before protein precipitation.
G6PDH enzymatic assay
To control the possible release of intracellular proteins
in CM, we measured the amount of the cytosolic marker
glucose 6-phospate dehydrogenase (G6PDH) in CM and
in whole cell lysate (WCL) by enzyme activity assay.
Bacterial pellets from a 50 ml culture, at stationary
growth phase, were lysed by sonication in an ice bath for
10 × 30 s with a 30 s interval between each ultrasonic
cycle, in 1 ml LB medium supplemented with the appro-
priate concentrations (1:100, [w/v]) of protease inhibi-
tors cocktail (Sigma-Aldrich, St. Louis, MO, USA) to
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twofold dilutions of the lysate were made in LB medium
supplemented as above to yield final concentrations of
50%, 25%, 10%, 5%, and 1% (v/v).
The enzymatic activity of G6PDH in 100 μl of CM and
in serial dilutions of WCL was measured spectrophoto-
metrically at 30°C by following the rate of NADP+ re-
duction at 340 nm according to the method described
by Bergmeyer et al. [18].
SDS PAGE analysis of intracellular and secreted proteins
B. clausii OC, SIN, NR and T cells suspended in CM were
collected from parallel sample preparation at stationary
growth phase (24 h). After separating cells from CM,
WCL was generated by sonicating the cell pellets. Briefly,
cell pellets were solubilized in Laemmli buffer [19] with-
out sodium dodecyl sulfate (SDS), bromophenol blue, and
β-mercaptoethanol, supplemented with 1/100, (v/v) prote-
ase inhibitors cocktail. The suspension was sonicated as
above. The lysate was cleared from insoluble material by
centrifugation for 20 min at 12000 × rpm at 4°C. The
resulting WCL supernatants and CM samples were pre-
cipitated with trichloroacetic acid (TCA) at 10% final con-
centration (w/v). Precipitates were solubilized in Laemmli
sample buffer [19] and equal amount of proteins of CM
and WCL were fractionated by polyacrylamide gel electro-
phoresis (SDS-PAGE) 12,5%.
Intracellular and secreted protein sample preparation for
2-DE analysis
Samples of the four O/C, SIN, N/R and T B. clausii
strains suspended the LB medium, were taken at the
early exponential growth phase (8 h), late exponential
growth phase (16 h) and stationary growth phase (24 h)
(Additional file 1: Figure S1). Cell proteins were prepared
as previously described [20], with some modifications.
Briefly, cells were collected by centrifugation at 6500 rpm
for 30 min at 4°C (Sorvall RT 6000 B, DuPont), from
50 ml of culture suspension. Cell pellets were washed
twice with phosphate-buffer, suspended in lysis buffer
(7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 50 mM DTT,
0.5% (w/v), IPG-buffer (GE Healthcare) pH 3–10
supplemented with 1 mM PMSF and disrupted by sonic-
ation as previously described. Insoluble material was sepa-
rated by centrifugation at 13000 rpm for 30 min at 4°C.
Raw protein extracts were precipitated with three volumes
of cold acetone, washed twice with cold acetone, air-dried
and stored at - 80°C until use.
In order to obtain the secreted proteins, supernatants
were subject to filtration through a 0.2 mm nitro-cellulose
filter (Millipore, Billerica, MA, USA) and treated with 10%
(w/v) TCA for 30 min. The aggregated proteins were pre-
cipitated by centrifugation, washed three times with 10 ml
of cold 90% acetone, air-dried and stored at −80°C until use.Cell protein extracts and precipitated proteins from CM
were dissolved in the lysis buffer and centrifuged (45 min ×
15000 × g, 4°C) to remove any indissoluble material before
two-dimensional electrophoresis (2-DE) analyses.
Protein concentration was determined using the Bio-
Rad Protein Assay kit (Bio-Rad Laboratories, Hercules,
CA, USA), according to the manufacturer’s instruction
[21], with bovine serum albumin, as standard protein.
2-DE analyses
B. clausii intracellular proteins and CM proteins were sep-
arated by 2-DE essentially as described in Gorg et al. [22]
and Hochstrasser et al. [23]. Isoelectric focusing (IEF) was
carried out at 20°C with the Ettan IPGphor Isoelectric Fo-
cusing System (GE Healthcare) by using, in the first ex-
periment, 24 cm immobilized pH gradient strips (IPG)
with a linear pH gradient 3–10 (GE Healthcare) for an
overview of total protein distribution pattern. To better re-
solve protein spots, in a second experiment, we used a
non-linear (NL) 3–10 pH gradient strip. To zoom the spe-
cific region of the gel, IPG strips pH 4–7 were also used.
The IPG strips were rehydrated overnight at room
temperature in a rehydration solution and 250 μg of pro-
tein sample was applied by cup loading. Focusing was car-
ried at 90 kVh total. After focusing, the IPG strips were
equilibrated for 15 min in the equilibration buffer (50 mM
Tris/HCl, pH 8.8, 6 M urea, 30% glycerol, 2% SDS, trace
of bromophenol blue) containing 1% DTT, and for further
15 min in the same equilibration buffer containing 2.5%
iodoacetamide and 0.5% bromophenol blue. The second-
dimension gel electrophoresis (SDS-PAGE) was carried
out using the vertical slab separation unit Ettan Dalt II
System (GE Healthcare). Homogeneous SDS 12.5% poly-
acrylamide gel was used in a Laemmli system [19] at a
constant current of 15 mA gel-1 and at 10°C until the
bromophenol blue dye front reached the bottom of the
gel. Molecular mass markers and pI standards were from
Bio-Rad. After separation, 2-DE gels were stained using
Coomassie Blue Colloidal dye (Sigma-Aldrich, St. Louis,
MO, USA), allowing quantitative comparison of spot in-
tensity. Bacterial cells were cultured in triplicate. CM
from each biological repeat, i.e. resulting from three in-
dependent cultures, were collected before protein ex-
traction and each protein sample was run in triplicate.
(Additional file 2: Figure S2).
The eventual presence of proteinaceous compounds in
the LB medium was excluded by 2-DE analysis of the LB
protein component precipitated by treatment with 10%
TCA (Additional file 3: Figure S3).
Image analysis
Stained gels were scanned with an Image Scanner
(GE Healthcare) at 300 dpi resolution to acquire the gel im-
ages that were analyzed with Image-Master 2D Platinum
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out using the optimized setting values for spot intensity,
spot area and saliency determined by applying real-time fil-
ters in order to minimize the detection of artifacts and to
maximize the real spot detection. After spot detection,
manual spot editing was carried out to remove eventual ar-
tifacts that escaped the filtering process.
Three master gels from each O/C, SIN, N/R and T
samples were used to create the four match.
Reproducible landmarks were used to match spots.
Relative spot volume (% vol.), i.e. digitized staining in-
tensity integrated over the area of the individual spot di-
vided by the sum of volume of all spots in the gel and
multiplied by 100, was used for spot quantification [24].
At the final level of matching, the four groups of gels
were matched and a composite synthetic gel was
obtained containing all spots present in at least two gels.
The match identification number (ID) was used to iden-
tify all spots in a match. Spots present in all the gel im-
ages of one of the four classes but absent in the others,
were considered to contain proteins expressed uniquely
by one strain. Spots present in all the gels of the four
classes and exhibiting an intensity difference between
the four strains with a P value < 0.05, using the two-
tailored Student’s t-test for equal or unequal variance
(depending on the calculated variance of spots), were
considered to contain proteins differentially expressed.
Protein identification by MALDI-TOF-MS
Spots were excised from 2-DE gels and in-gel triptych
digestion was carried out following the procedure de-
scribed by Shevchenko et al. [25]. Matrix Assisted Laser
Desorption Ionization - Time of Flight - Mass Spectrom-
etry (MALDI-TOF-MS) analyses were carried out on a
Voyager DE PRO mass spectrometer (Applied Biosystems
Foster City, CA) operating in positive-ion reflectron mode.
Mass spectra were calibrated using as internal standards
the monoisotopic peaks of angiotensin (m/z 931.5154)
and of adrenocorticotropic hormone (ACTH) fragment
18–39 (m/z 2465.1989) and data were processed using the
DataExplorer 5.1 software (Applied Biosystems). Peak lists
were obtained by further processing the mass spectra
with the Mascot Wizard tool (www.matrixscience.com)
and manually inspected. Protein identification was
achieved by using peak lists for database searches
against the NCBInr database using the Mascot software
(http://www.matrixscience.com/). Parameters for all
searches were as follows: all entries as taxonomic category,
trypsin as enzyme, carbamidomethyl as fixed modification
for cysteine residues, up to one missing cleavage and up to
50 ppm as mass tolerance. Identified proteins were classi-
fied on the basis of their biological functions using the bio-
informatic resource KEGG (Kyoto Encyclopedia of Genes
and Genomes, http://www.genome.jp/kegg/).Results
To rule out the possible presence of intracellular proteins
in CM, we measured the amount of the cytosolic marker
G6PDH in CM. The total amount of G6PDH enzymatic ac-
tivity detected in CM was compared with that found to be
associated with serial dilutions of WCL samples. As shown
in Figure 1, and in Additional file 4: Table S1, the total
G6PDH activity detected in CM was less than that found in
1% of the corresponding WCL sample. In addition, an
equal amount of CM and WCL proteins of the four strains
was analyzed by both SDS-PAGE (Figure 2) and 2-DE
(Figure 3), allowing us to directly compare the CM and
WCL protein profiles. The electrophoretic patterns thus
obtained showed clearly distinct protein profiles of CM and
WCL for the four B. clausii strains. These results confirmed
that the proteins detected in CM did not derive from cell lysis
occurring during the cultivation or processing procedures.
Secretome analysis of the four B. clausii strains
Literature data show that the highest levels of protein secre-
tion were observed when bacterial cells were grown in rich
medium and during the stationary growth phase [26-29]. In
agreement with these findings, our results showed a more
abundant and rich repertoire of secreted proteins at station-
ary growth phase (Additional file 5: Figure S4).
In fact, minor differences in the secretome profiles
were observed by comparing the proteomic maps of se-
creted proteins of bacteria cells at stationary and late ex-
ponential growth phase. At early exponential growth
phase the total secreted proteins were weakly detectable
(Additional file 5: Figure S4). Therefore, comparative
proteomic analysis of the overall secretome of the four
O/C, SIN, N/R and T B. clausii strains, was performed
on cells grown at stationary growth phase (24 h).
The four strains secreted a large array of proteins, dis-
tributed over a wide range of pI values and molecular
masses. In Figure 4, representative gels of secretome of
the four strains, obtained in the pI range 3–10 and 4–7
are shown. The overall position of protein spots was
similar in the gels of the four strains.
The number of spots observed in the gels was similar
in the four classes without significant differences (431 ±
38 in OC, 453 ± 26 in SIN, 410 ± 30 in NR and 455 ± 42
in T). Also the percentage of matches between gels from
the same class (intra-class) and from the four different
classes (inter-classes) was similar (around 60%). Some
spots were not considered for analysis because they were
present only in a subset of gels and exhibited variability.
Only protein spots systematically present in at least two
of tree gels of each class, were considered in the analysis
Among this group of spots, only those showing a differ-
ent mean intensity in the gels from the four strains with a
p < 0.05, applying the restrictive two tailored Student’s
t-test, were considered to contain proteins differentially
Figure 1 G6PDH enzymatic activity detected in CM and WCL of the four OC, SIN, NR and T B. clausi strains grown aerobically at 37°C
in LB medium to stationary growth phase. CM and bacterial cells were harvested and assayed as described in Materials and Methods. G6PDH
activity in CM was compared with that associated with deliberately lysed cell (WCL). The data shown are the means of measurements from three
independent experiments. 0.01 units of G6PDH were assayed as a control in each experiment.
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pected pronounced variations in mean intensity of 26 spots,
marked in Figure 4, were revealed.
Proteins contained in these spots were identified ap-
plying the Peptide Mass Fingerprinting (PMF) strategy
and results are summarized in Table 1.
The secreted proteins differentially expressed by the
four stains, could be classified on the basis of their bio-
logical function among several categories.
(i.)Eight enzymes related to carbohydrate metabolism:
dihydrolipoamide dehydrogenase (Lpd), spot 107,Figure 2 SDS-PAGE analysis of whole cell proteins (WCL) and CM protei
indicate the CM protein bands which are different from those in WCL. The SD
independent experiments.expressed at higher level in strains SIN, and T;
succinate semialdeyde dehydrogenase (Ssdh), spot
207 which comigrated with dihydrolipoamide
dehydrogenase; acetyl CoA synthetase (AcsA), spots
216 overexpressed in SIN strain; glucose-6-
phosphate isomerase (Pgi), spot 231, present in
higher amount in SIN strain; enolase (Eno), spot
309, underexpressed in T strain; alcohol
dehydrogenase (AdhA), spot 382, overexpressed in
SIN and NR strains and malate dehydrogenase
(Mdh) and sugar phosphate epimerase, spot 439,
which co-migrated.ns of the four OC, SIN, NR and T B. clausii strains. Arrows
S-PAGE protein profile shown is representative of three
OC SIN NR T 
Figure 3 Comparison of WCL proteins maps and secreted protein maps of the four O/C, SIN, N/R and T B. clausii strains at stationary
growth phase.
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various transport systems: two oligopeptide ABC
transporters (ABC2414 and ABC3090) which co-
migrated spots 33, expressed at higher level in
strains OC and NR; Mn2+/Zn2+ ABC transporter,
spot 247, overexpressed in SIN strain.OC SIN 
33 





















































































Figure 4 2-DE analysis of secretomes of the four O/C, SIN, N/R, and T B.
bacterial cells in stationary growth phase separated using pH 3–10 N.L IPG str
indicated by match ID. Proteins contained in these spots were identified by M
four B. clausii secretomes from bacterial cells in stationary growth phase in th
strains, are indicates by numbers referred to Figure 4A.(iii.) Two proteases: chain A, alkaline protease (AprE),
spots 532, 593 and 693, secreted at more abundant
level in strains OC and T and aminopeptidase
(AmpS), spot 245, overexpressed in SIN strain.
(iv.) Four proteins involved in detoxification: carbonic
anhydrase, spot 485, was detected at significantlyNR T 



































































clausii strains. A. 2-DE maps of the four B. clausii secretomes from
ips. Protein spots showing different intensity in the four strains are
ALDI-TOF-MS and database searches (Table 1). B. 2-DE maps of the
e 4–7 pI range. Protein spots showing different intensity in the four


























309 eno Phosphopyruvate hydratase (Enolase) gi|
56964781









382 adhA Alcohol dehydrogenase gi|
56961828
ABC0046 37979 5.26 230 15 69 Cytoplasm.
107 lpd Dihydrolipoamide dehydrogenase gi|
56964182







207 lpd Dihydrolipoamide dehydrogenase gi|
56964182









ABC0331 51161 5.23 109 15 44
216 acsA Acetyl-CoA synthetase gi|
56964524
ABC2760 64388 5.24 293 26 50
439 mdh Malate dehydrogenase gi|
56964478








Sugar Phosphate isomerase/epimerase gi|
56962569
ABC0795 36078 5.18 227 15 83
231 pgi Glucose-6-phosphate isomerase gi|
56964670






























247 mntA Mn2+/Zn2+ ABC transporter substrate-binding protein gi|
56965719






















Table 1 Secreted proteins differentially expressed by the four probiotic strains of B. clausii, as identified by PMF strategy (Continued)
Proteases/
Peptidases
532 aprE Chain A, Alkaline M-Protease Form I Crystal Structure gi|
56966974







593 aprE Chain A, Alkaline M-Protease Form I Crystal Structure gi|
56966974







693 aprE Chain A, Alkaline M-Protease Form I Crystal Structure gi|
56966974







245 ampS Aminopeptidase gi|
56963895
ABC2130 45195 5.06 197 18 46 Secreted
with export
signal






120 cat Catalase gi|
56963055







156 cat Catalase gi|
56963055







164 cat Catalase gi|
56963055







694 2-cys Peroxiredoxin gi|
56964193





602 sodA Manganese Superoxide dismutase gi|
56963480









485 Carbonic anhydrase gi|
56964946




RNA synthesis 281 Transcriptional regulator gi|
56962515
ABC0741 47467 5.35 341 26 77 Secreted
with signal
peptides





















Table 1 Secreted proteins differentially expressed by the four probiotic strains of B. clausii, as identified by PMF strategy (Continued)
Structural
protein
451 hag Flagellin protein gi|
56965461










528 cwlC Acetylmuramoyl-L-Alanine amidase gi|
56962701






528 resD Two-component response regulator gi|
56963600
ABC1835 27512 5.17 95 9 40
Molecular
Chaperones
114 groEL molecular chaperone GroEL gi|
56962656
ABC0882 57240 4.76 33 66 Secreted Beck et al. FEMS
Microbiol Lett
2009, 297:6166
639 Hypothetical protein ABC0920 gi/
56962694
14960 4.40 109 6 73 Secreted Antelmann et al.
Genome Res.
2001 11: 1484
673 Hypothetical protein ABC2092 gi|
56963857
ABC2092 13501 5.41 130 10 84 Secreted Antelmann et al.
Genome Res.
2001 11: 1484
659 Hypothetical protein ABC2108 gi|
56963873
ABC2108 13099 5.55 120 8 59 Secreted Antelmann et al.
Genome Res.
2001 11: 1484
a. ID Spot numbers refer to Figure 4.
b. Gene.
c. Kegg Entry. Organism: B. clausii KSM-K16 (Bcl).
d. Theoretical molecular weight (kDa).
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peroxiredoxin, spot 694, detected in strain NR;
manganese superoxide dismutase (SodA),
spot 602, expressed at higher level in strain OC
and at very low level in strain T and catalase
(Cat), spots 120, 156 and 154, which migrated as
pearl chains, probably due to post translational
modifications, expressed at higher level in OC
and NR strains.
(v.) The molecular chaperone GroEL, spot 114,
overexpressed in strains SIN and NR.
(vi.) A structural flagella-related protein flagellin (Hag),
spot 451, significantly more abundant in strains NR
and T.
(vii.) One transcriptional regulator, spot 281,
overexpressed in SIN strain.
(viii.) A two-component response regulator, spot 674,
overexpressed in SIN and NR strains.
(ix.) Three proteins of unknown function: hypothetical
protein ABC 0920, spot 639; hypothetical protein
ABC2092 spot 659; hypothetical protein ABC2108,
spot 673.Figure 5 Semiquantitative expression profile, in the four strains, of id
spot is indicated with a match ID. The error bars (SEM) are indicated.These results are shown in Figures 5, 6 and summa-
rized in Table 1 and Additional file 6: Table S2.
Most of the identified extracellular proteins migrated
on the 2D gels at a position that was in good agreement
with their calculated molecular weight and isoelectric
point. Spots ID 593 and 693, containing chain A alkaline
protease, did not run at the estimated position. Most
likely, this was due to proteolytic processing upon export
from the cytoplasm. The two major degradation prod-
ucts of alkaline protease were both detected in the two
OC and T strains, which secreted high level of proteases
(Figure 4).
All the identified proteins were from B. clausii KSM-
K16 thus confirming the identification accuracy and the
similarity among the B. clausii KSM-K16 and the four
strains analyzed in this work.
Discussion
The four OC, SIN, NR and T, B clausii strains, are used
in a pharmaceutical preparation as probiotics for oral
bacteriotherapy and bacterioprophylaxis of gastrointestinal
disorders sometimes combined with the antibiotic therapy.entified proteins belonging to carbohydrate metabolism. Each
Figure 6 Expression profile in the four strains of other identified proteins. Each spot is indicated with a match ID. The error bars (SEM)
are indicated.
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applied to the secretome analysis of the four isogenic
strains. Each strain secreted a large repertoire of proteins
into the extracellular environment that comes into direct
contact with host compartments and can mediate host-
bacteria interactions and probiotic effects.
Although the genomes of the four B clausii strains are
very similar, as their life cycles, biology, and protein ex-
pression profiles [4], the comparative proteomic analysis
revealed, for the first time, unexpected variations in the
expression level of some secreted proteins between the
four strains at stationary growth phases and shed new
light on the specific secretome features of each strain.
The reported results highlighted phenotypic differences
between these strains, and suggested that regulatory cir-
cuits were differently active in determining secretion
levels of some proteins.
In particular, OC strain expressed at higher level enolase,
carbonic anhydrase, acetylmuramoyl-L-alanine amidase
and alkaline protease; SIN strain overexpressed enolase,
GroEL and two oligopeptide ABC transporters; NR strain
overexpressed enolase, GroEL, catalase, flagellin protein,
two oligopeptide ABC transporters and a transcriptional
regulator factor; T strain expressed the flagellin protein and
alkaline protease at very high level and overexpressed
acethilmuramoyl-L- amidase (Figure 5, Figure 6 and
Additional file 6: Table S2).
Many of the proteins identified in the present study
were already reported to be involved in the molecularmechanisms of probiotic actions, in particular in the
adaptation and colonization processes of the human
gastrointestinal tract (GIT) as well as in immunomodu-
latory mechanisms.
The presence of cytoplasmic proteins as secretome com-
ponents of the four B. clausii strains is not surprising. A
growing list of prokaryotic and eukaryotic proteins shows,
in fact, intracellular and extracellular dual localization
[30-32]. These cytoplasmic proteins are displayed on the
cell surface of a wide spectrum of Gram-positive and
Gram-negative bacteria [32,33], where they acquire a sec-
ondary ‘moonlighting’ function [34] important in bacteria-
host interactions.
Some of these proteins have been shown to have hu-
man plasminogen/fibronectin/mucus binding activity
and thus may be involved in adhesion and colonization
of GIT. Our proteomic analysis identified two potential
plasminogen-binding proteins: enolase, underexpressed
in T strain and flagellin overexpressed in NR and T
strains.
The surface-associated α-enolase of several, mainly
Gram-positive pathogenic bacteria, was identified as a
major protein component with plasminogen binding
capacity, thus enhancing the proteolytic plasmin activity
important in the pathogenesis process [33]. The mecha-
nisms used by our strains to attach to intestinal mucosa
might mimic those of pathogens, therefore mediating
the exclusion of enteropathogenic bacteria by competing
for binding sites [35].
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lecular chaperone GroEL which has been reported to act
as a moonlighting protein, being part of the extracellular
proteome of several probiotic species [36]. GroEL was also
shown to have a key role in the adhesion mechanism of
probiotics, being able to bind to mucins and human intes-
tinal epithelial cells [37,38]. Moreover, this protein is in-
volved in immunomodulation, stimulates interleukin-8
secretion in macrophages and HT29 cells in CD14-
dependent pro-inflammatory response and mediates the
aggregation of the gastric pathogen H. pylori [39].
Flagellin protein has been recently recognized to be a
potent activator of intestinal epithelial pro-inflammatory
gene expression [34,40]. It has been suggested that the
stimulation induced by flagellin secreted by probiotics
would not reach the threshold level necessary for the in-
duction of a pro-inflammatory response, producing in-
stead an activation of the immune system through the
production of IL-8 and “human βdefensin” (2 hBD-2) [41]
which counteract bacterial adherence and invasion [42].
Transporter substrate-binding proteins and proteins in-
volved in cell wall metabolism, also identified in the
present study, have been found to have potential probiotic
activities [43]. ABC transporters represent a major class of
secreted proteins in Gram-positive bacteria [38], having a
key role in nutrient intake and chemotaxis and in anti-
biotic and antifungal resistance with considerable medical
relevance [44]. We have identified two ABC transporter
substrate-binding proteins expressed at higher level in the
secretome of strains NR and OC (Figure 4, Figure 6).
The cell wall-metabolizing protein acetylmuramoyl-
L-alanine amidase, which catalyzes turnover and degrad-
ation of peptidoglycan [45], was found to be overexpressed
in OC strain.
All the four B. clausii strains secreted at different level
catalase, manganese superoxide dismutase and 2-cys
peroxiredoxin, enzymes of the redox system (Figure 4,
Figure 6). Recently it has been demonstrated that genetic-
ally engineered lactic acid bacteria producing antioxidant
enzymes, could be used to prevent or decrease the severity
of certain intestinal pathologies caused by reactive oxygen
species; catalase and superoxide dismutase were also eval-
uated from an immune stimulating (cytokine producing)
point of view [46]. Recently, peroxiredoxins received con-
siderable attention as a new and expanding family of thiol-
specific antioxidant proteins through their peroxidase
activity [47]. As the anti-oxidant potential of probiotics is
currently the focus of attention, the four strains that differ-
entially expressed these enzymes, could be explored as
prospective antioxidants to manage oxidative stress.
The four strains expressed differentially a cytoplasm
membrane associated protein dihydrolipoamide dehydro-
genase (Figure 4, Figure 6). It has been suggested that this
enzyme might have a fundamental role in membraneprocesses such as transport of solutes into and out of the
cell [48].
Strain NR secreted higher amount of aminopeptidase.
This protein participates in a wide range of biological
processes, from protein maturation or degradation to
cell cycle control. The higher secretion of aminopepti-
dase probably indicates a higher rate in recycling small
peptides that become available through the degradation
of proteins/peptides in the culture medium, and serve as
amino acid sources to sustain cell growth under nutrient
limitation. They can, also, play signaling roles in the ini-
tiation of different cellular processes such as competence
development and sporulation [20].
Our comparative proteomic analysis identified proteins
differentially expressed in the secretome of the four B.
clausii indicating that each strain is characterized by a
specific secretion pattern, despite their genotypic simi-
larity, which can contribute to specific interaction with
host cells. It is conceivable that the clinical effects of oral
administration of this preparation are contributed by the
sum of the specific probiotic properties associated with
each strain. The proteins identified in the present study
open the way to further studies aimed at investigating
their claimed probiotic function.Conclusions
In this study comparative proteomics was used to analyze
the secretome of four isogenic B. clausii probiotic strains.
Results provided an overview of secretome patterns of the
four strains and showed clear different features of protein
secretion, indicating strain specific profile of secretomes.
Differential expression of proteins with claimed probiotic
activity could reflect specific ability of each strain to act as
probiotics.
Secretome analyses could then represent a powerful
tool to identify specific proteins, which may serve as
bacterial biomarkers for the selection of strains with the
best probiotic potential.Additional files
Additional file 1: Figure S1. Growth curve of OC, SIN, NR and T B.
clausii strains. Cell growth was quantified in LB medium by measuring
the optical density at 595 nm.
Additional file 2: Figure S2. DE. Reproducible gel images of proteins
secreted by the four strains. Equivalent amounts (250 μg) of secreted
proteins, from cells in the stationary growth phase were separated, using
linear pH ranges 3–10 IPG strips. SDS-PAGE was performed with 12.5%
acrylamide. Gels were stained with Colloidal Coomassie brilliant blue G-250.
Additional file 3: Figure S3. 2-DE maps of the LB medium without cell
inoculation, incubated to 37°C for 24 h. Equal amount of TCA-
precipitated volume of CM with and without bacteria cells, at stationary
growth phase, was subjected to 2-DE analysis, using linear pH ranges 3–
10 IPG strips. SDS-PAGE was performed with 12.5% acrylamide. Gels were
stained with Colloidal Coomassie brilliant blue G-250.
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http://www.proteomesci.com/content/11/1/28Additional file 4: Table S1. G6PDH enzymatic activity of CM and WCL
of the four OC, SIN, NR and T B. clausii strains. The four strains were
grown aerobically at 37°C in LB medium to stationary growth phase. Cells
and CM were harvested and assayed as described in Materials and
Methods. G6PDH activity was assayed by following the reduction of
NADP at 340 nm. The reaction was started by addition of either WCL or
cell-free CM. The final concentrations in the reaction mixture were Glu-
6P, 1.0 mM; NADP, 0.4 mM; MgCI2, 6.9 mM; and Tris-HC1, pH 7.8, 50 mM.
Values reported are the mean of three determinations. 0.01 units of
G6PDH were assayed as a control in each experiment. *One activity unit
is defined as the amount of enzyme that catalyzes the transformation of
1 mmol of substrate per min under the conditions of the assay.
Additional file 5: Figure S4. 2-DE analysis of secretomes of cell in a)
early exponential growth phase, b) late exponential growth phase, c)
stationary growth phase. Equivalent amounts (250 μg) of secreted
proteins, were separated, using NL pH ranges 3–10 IPG strips (GE
Healthcare). SDS-PAGE was performed with 12.5% acrylamide. Gels were
stained with Colloidal Coomassie brilliant blue G-250.
Additional file 6: Table S2. Image analysis of 2-DE maps of secretome
of the four B. clausii strains: Spots showing different mean intensity in the
four maps are listed , together with the corresponding identified
proteins. Reported values are the mean + SD of spot volumes (% vol)
observed in the OC, SIN, NR, and T, proteomic electropherograms
examined for each of three independent cultivation taken at the
stationary (24 h) growth phase. Proteins are listed according to their
respective match spot identification numbers (ID). The match ID is
referred to those reported in Figure 4.
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